nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexbrompheniramine—Captodiame—DRD3—bipolar disorder	0.0371	0.217	CrCbGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.0348	0.042	CbGpPWpGaD
Dexbrompheniramine—Orphenadrine—GRIN1—bipolar disorder	0.0344	0.201	CrCbGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—DRD5—bipolar disorder	0.0343	0.0414	CbGpPWpGaD
Dexbrompheniramine—Captodiame—HTR2C—bipolar disorder	0.0312	0.182	CrCbGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—DRD5—bipolar disorder	0.0288	0.0348	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—HTR1A—bipolar disorder	0.02	0.0241	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—HTR2C—bipolar disorder	0.0193	0.0233	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—DRD1—bipolar disorder	0.0193	0.0233	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—DRD3—bipolar disorder	0.0187	0.0226	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—DRD4—bipolar disorder	0.0182	0.0219	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—DRD2—bipolar disorder	0.0169	0.0204	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0168	0.0203	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0166	0.0201	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0162	0.0196	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0162	0.0196	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—CPLX1—bipolar disorder	0.0158	0.0191	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0157	0.019	CbGpPWpGaD
Dexbrompheniramine—Chlorphenamine—SLC6A3—bipolar disorder	0.0156	0.091	CrCbGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0153	0.0184	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0142	0.0172	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.0142	0.0171	CbGpPWpGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—GATA3—bipolar disorder	0.013	0.0157	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.0129	0.0156	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.0129	0.0156	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—HTR2A—bipolar disorder	0.0118	0.0143	CbGpPWpGaD
Dexbrompheniramine—Chlorphenamine—SLC6A4—bipolar disorder	0.0116	0.068	CrCbGaD
Dexbrompheniramine—Promazine—DRD4—bipolar disorder	0.0114	0.0664	CrCbGaD
Dexbrompheniramine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—bipolar disorder	0.0111	0.0134	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.0107	0.0129	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.0105	0.0127	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.0103	0.0124	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.0103	0.0124	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.0103	0.0124	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.01	0.0121	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00996	0.012	CbGpPWpGaD
Dexbrompheniramine—Promazine—DRD1—bipolar disorder	0.00961	0.0562	CrCbGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—DGKH—bipolar disorder	0.00936	0.0113	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIK2—bipolar disorder	0.00909	0.011	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIN1—bipolar disorder	0.00889	0.0107	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GAD1—bipolar disorder	0.00871	0.0105	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00837	0.0101	CbGpPWpGaD
Dexbrompheniramine—Promazine—HTR2C—bipolar disorder	0.00822	0.0481	CrCbGaD
Dexbrompheniramine—KCNH2—Neuronal System—CACNB2—bipolar disorder	0.0081	0.00977	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00776	0.00936	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.00748	0.00903	CbGpPWpGaD
Dexbrompheniramine—Promazine—DRD2—bipolar disorder	0.00677	0.0396	CrCbGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00662	0.00798	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00661	0.00797	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00649	0.00783	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SNAP25—bipolar disorder	0.00647	0.00781	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.00632	0.00763	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—TACR1—bipolar disorder	0.00603	0.00728	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIN2B—bipolar disorder	0.00585	0.00706	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.0058	0.007	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SLC6A3—bipolar disorder	0.00577	0.00696	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—ADCY2—bipolar disorder	0.00573	0.00691	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00567	0.00684	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.00539	0.00651	CbGpPWpGaD
Dexbrompheniramine—Promazine—HTR2A—bipolar disorder	0.00523	0.0306	CrCbGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—TAC1—bipolar disorder	0.00492	0.00593	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—COMT—bipolar disorder	0.00491	0.00592	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—MAOA—bipolar disorder	0.00487	0.00588	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00482	0.00582	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.0044	0.0053	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD5—bipolar disorder	0.00432	0.00521	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00431	0.0052	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00399	0.00482	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00399	0.00482	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00386	0.00466	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.00375	0.00452	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00373	0.0045	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00373	0.0045	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00361	0.00435	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.0035	0.00423	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00331	0.00399	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00326	0.00394	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00326	0.00393	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00319	0.00385	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00319	0.00385	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—ADM—bipolar disorder	0.00312	0.00377	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00309	0.00373	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—TSHB—bipolar disorder	0.00304	0.00367	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—TACR1—bipolar disorder	0.00304	0.00367	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.003	0.00362	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00296	0.00357	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.0028	0.00337	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DGKH—bipolar disorder	0.00267	0.00322	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00265	0.00319	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR1A—bipolar disorder	0.00252	0.00304	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—TAC1—bipolar disorder	0.00248	0.00299	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD5—bipolar disorder	0.00244	0.00294	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR2C—bipolar disorder	0.00243	0.00293	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD1—bipolar disorder	0.00243	0.00293	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DGKH—bipolar disorder	0.00242	0.00292	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—RGS4—bipolar disorder	0.00239	0.00289	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD3—bipolar disorder	0.00236	0.00284	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00229	0.00276	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD4—bipolar disorder	0.00229	0.00276	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD5—bipolar disorder	0.00222	0.00267	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—RGS4—bipolar disorder	0.00217	0.00262	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD2—bipolar disorder	0.00213	0.00257	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00196	0.00236	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00185	0.00223	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—ADM—bipolar disorder	0.00176	0.00213	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—TSHB—bipolar disorder	0.00172	0.00207	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00172	0.00207	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—TACR1—bipolar disorder	0.00172	0.00207	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—TRPC3—bipolar disorder	0.00168	0.00203	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—ADM—bipolar disorder	0.0016	0.00193	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00156	0.00189	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—TACR1—bipolar disorder	0.00156	0.00188	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—TSHB—bipolar disorder	0.00156	0.00188	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PDE4B—bipolar disorder	0.00156	0.00188	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AKR1C4—bipolar disorder	0.00155	0.00188	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR2A—bipolar disorder	0.00149	0.0018	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DGKH—bipolar disorder	0.00143	0.00173	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00142	0.00172	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—TAC1—bipolar disorder	0.0014	0.00169	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD1—bipolar disorder	0.00137	0.00166	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR2C—bipolar disorder	0.00137	0.00166	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD3—bipolar disorder	0.00133	0.00161	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD5—bipolar disorder	0.00131	0.00158	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR1A—bipolar disorder	0.00129	0.00156	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD4—bipolar disorder	0.00129	0.00156	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RGS4—bipolar disorder	0.00128	0.00155	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—TAC1—bipolar disorder	0.00127	0.00154	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD1—bipolar disorder	0.00125	0.00151	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR2C—bipolar disorder	0.00125	0.00151	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—ADCY2—bipolar disorder	0.00122	0.00147	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD3—bipolar disorder	0.00121	0.00146	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD2—bipolar disorder	0.0012	0.00145	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—POMC—bipolar disorder	0.00119	0.00144	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD4—bipolar disorder	0.00117	0.00142	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—ADCY2—bipolar disorder	0.0011	0.00133	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD2—bipolar disorder	0.00109	0.00132	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TRPC3—bipolar disorder	0.000992	0.0012	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ADM—bipolar disorder	0.000946	0.00114	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TSHB—bipolar disorder	0.000922	0.00111	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TACR1—bipolar disorder	0.000922	0.00111	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PDE4B—bipolar disorder	0.000922	0.00111	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000843	0.00102	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	0.000766	0.000923	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR1A—bipolar disorder	0.000763	0.000921	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TAC1—bipolar disorder	0.000752	0.000907	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR2C—bipolar disorder	0.000737	0.000889	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD1—bipolar disorder	0.000737	0.000889	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	0.000717	0.000865	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD3—bipolar disorder	0.000714	0.000861	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	0.000711	0.000858	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD4—bipolar disorder	0.000693	0.000836	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	0.000673	0.000812	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	0.000652	0.000787	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	0.00065	0.000784	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD2—bipolar disorder	0.000646	0.000779	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—POMC—bipolar disorder	0.000611	0.000738	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	0.000585	0.000705	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—S100B—bipolar disorder	0.000568	0.000686	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NRG1—bipolar disorder	0.000502	0.000605	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	0.000452	0.000546	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	0.000364	0.000439	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—POMC—bipolar disorder	0.000361	0.000436	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—INS—bipolar disorder	0.000359	0.000433	CbGpPWpGaD
